Several genes (e.g., PRRC2A, PSMB8, BAG6, GPSM3, PBX2, etc.)have been identified with molecular commonalities in MetS and RA, AS, SLE and SS, which may serve as potential targets for shared treatments. The gene discussed is PRRC2A; the disease is synovial sarcoma.